Abnormal Expression of WSB1 in Lung Adenocarcinoma: A Potential Prognostic and Immunotherapeutic Sensitivity Biomarker. (2025). Advances in World Medical Research, 1(2), 48-63. https://doi.org/10.71204/1bcv8650